Johnson Matthey PLC (LON:JMAT – Get Free Report) has been given an average rating of “Moderate Buy” by the five analysts that are currently covering the stock, MarketBeat.com reports. Two equities research analysts have rated the stock with a hold rating and three have issued a buy rating on the company. The average 12 month price target among brokerages that have issued ratings on the stock in the last year is GBX 2,298.33.
JMAT has been the subject of a number of recent research reports. UBS Group restated a “neutral” rating and issued a GBX 2,200 price objective on shares of Johnson Matthey in a report on Friday, May 22nd. Jefferies Financial Group reaffirmed a “restricted” rating on shares of Johnson Matthey in a report on Friday, May 29th. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating and issued a GBX 2,400 target price on shares of Johnson Matthey in a research report on Monday, July 6th. Finally, Berenberg Bank upped their price target on shares of Johnson Matthey from GBX 2,100 to GBX 2,300 and gave the company a “buy” rating in a research report on Monday, June 1st.
Get Our Latest Analysis on JMAT
Insider Buying and Selling
Johnson Matthey Price Performance
JMAT stock opened at GBX 1,948.71 on Friday. The company has a debt-to-equity ratio of 69.69, a current ratio of 1.56 and a quick ratio of 0.76. Johnson Matthey has a one year low of GBX 1,730.72 and a one year high of GBX 2,434. The stock has a market cap of £3.27 billion, a PE ratio of -34.07, a P/E/G ratio of 49,242.50 and a beta of 0.94. The firm has a 50 day simple moving average of GBX 2,070.78 and a two-hundred day simple moving average of GBX 2,101.91.
Johnson Matthey (LON:JMAT – Get Free Report) last announced its quarterly earnings data on Thursday, May 28th. The company reported GBX 128.50 earnings per share for the quarter. Johnson Matthey had a negative return on equity of 4.66% and a negative net margin of 0.76%.The company had revenue of GBX 1,257.30 billion for the quarter. On average, analysts predict that Johnson Matthey will post 173.4112903 EPS for the current fiscal year.
About Johnson Matthey
Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources. Today more than 13,000 Johnson Matthey professionals collaborate with their network of customers and partners to make a real difference to the world around us.
Featured Articles
- Five stocks we like better than Johnson Matthey
- Why Fastenal’s Latest Drop Could Be Its Biggest Opportunity Yet
- 3 Overlooked Energy ETFs Delivering Strong Returns and Income
- 3 Space Stocks That Could Outshine SpaceX After Its IPO
- JPMorgan’s Q2 Strength Gives the Stock Rally New Support
Receive News & Ratings for Johnson Matthey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson Matthey and related companies with MarketBeat.com's FREE daily email newsletter.
